Pia Christensen (@AHCJ_Pia) is the managing editor/online services for AHCJ. She manages the content and development of healthjournalism.org, coordinates social media efforts of AHCJ and assists with the editing and production of association guides, programs and newsletters.
Even if you only cover health care occasionally, you run across myriad medical studies and health claims. The results and claims often seem conflicting and confusing. But understanding evidence-based medicine will help journalists explore for their audiences the science and the policy decisions that impact lives.
The program is set and the speakers are confirmed for next month’s Journalism Workshop on Evidence-Based Medicine.
Sessions will include:
The connections and disconnections of science and policy
Getting up to speed on clinical studies
Research tools for evidence-based stories
How to report on scientific fraud
Understanding and reporting on screening evidence
Digging into statistics
How to use anecdotes and narratives while sticking to evidence
Efforts to improve health care quality and safety are mostly missing one significant source of concern: diagnostic errors, according to a report Tuesday from the Institute of Medicine. Improving Diagnosis in Health Care is the fourth in a series of IOM reports on patient safety.
In this Sept. 22 report, the IOM said that about 5 percent of U.S. adults who seek outpatient care experience a diagnostic error each year. Diagnostic errors contribute to about 10 percent of patient deaths, and account for about 6 percent to 17 percent of adverse events in hospitals. Continue reading →
Mary Otto, a Washington, D.C.-based freelancer, is AHCJ's topic leader on oral health, curating related material at healthjournalism.org. She welcomes questions and suggestions on oral health resources at firstname.lastname@example.org.
Under the influence of the sugar industry decades ago, federal health officials stepped back from an ambitious campaign to wipe out tooth decay, according to a newly published study.
Researchers from the University of California, San Francisco, analyzed previously unexplored sugar industry documents from the 1960s and early 1970s to reach their conclusions. The paper describing the findings appeared in March in PLOS Medicine.
At a conference last year, Michael Laposata, M.D., Ph.D., one of the nation’s best known pathologists, explained how clinical laboratories could deliver more value to patients, physicians, and health insurers. To do so, pathologists and laboratory scientists need to provide more detailed explanations about lab test results because even physicians who order genetic and molecular tests are often confused about the results, said Laposata, chairman of the Department of Pathology at the University of Texas Medical Branch.
When he explains test results to ordering physicians, he frequently refers to an “allele” which is one of two or more versions of a gene, he said. When he does, physicians sometimes ask, “What’s an allele?”
His anecdote is telling following President Obama’s announcement last month that he recommended spending $215 million on the precision medicine initiative. The announcement was correctly hailed as an important and needed investment in medical technology. “Precision medicine” is described by the National Institutes of Health as “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” Continue reading →